Evidence map›Paper›PMID 41145441›Full record

ArticleThe Journal of international medical research2025

Case report: Metformin-induced hemolytic anemia in a glucose-6-phosphate dehydrogenase-deficient patient.

Alaa M Salamat, Hani M Ammar, Ahmed I Alsagheir, Hayat S Mushcab

Abstract readCase Reports
In one paragraph

Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alaa M SalamatDepartment of Internal Medicine, Johns Hopkins Aramco Healthcare, Saudi Arabia.
Hani M AmmarCardiology Department, Johns Hopkins Aramco Healthcare, Saudi Arabia.
Ahmed I AlsagheirOncology Department, Johns Hopkins Aramco Healthcare, Saudi Arabia.
Hayat S MushcabResearch Office, Johns Hopkins Aramco Healthcare, Saudi Arabia.ORCID 0000-0003-4398-7020

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report describes a male patient in his early 60s with a documented history of glucose-6-phosphate dehydrogenase deficiency, who developed significant hemolytic anemia following the initiation of metformin therapy for newly diagnosed type 2 diabetes mellitus.

Indexed as

Anemia, HemolyticDiabetes Mellitus, Type 2Glucosephosphate Dehydrogenase DeficiencyHypoglycemic AgentsMetforminHumansMaleMiddle AgedHypoglycemic AgentsMetformindiabetes mellitusGlucose-6-phosphate dehydrogenasehemolytic anemiametformintype 2 diabetes

Identifiers

PMID41145441
PMCPMC12576054

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.